CREDIT SUISSE AG/ - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$11
-100.0%
7
-100.0%
0.00%
Q3 2022$143,000
+5.1%
120,969
+0.7%
0.00%
Q2 2022$136,000
-66.7%
120,074
-12.1%
0.00%
Q1 2022$409,000
+21.0%
136,661
+7.0%
0.00%
Q4 2021$338,000
-24.9%
127,750
+3.0%
0.00%
Q3 2021$450,000
-1.7%
123,983
+17.8%
0.00%
Q2 2021$458,000
-18.4%
105,290
-35.7%
0.00%
Q1 2021$561,000
-52.4%
163,820
-51.3%
0.00%
-100.0%
Q4 2020$1,179,000
+28.3%
336,680
-12.1%
0.00%0.0%
Q3 2020$919,000
+210.5%
383,225
+137.4%
0.00%
Q2 2020$296,000
+19.8%
161,425
+1.5%
0.00%
Q1 2020$247,000
-63.8%
159,020
-50.1%
0.00%
Q4 2019$683,000
+19.0%
318,858
+4.0%
0.00%
Q3 2019$574,000
-14.2%
306,618
+19.4%
0.00%
-100.0%
Q2 2019$669,000
+49.3%
256,715
+47.2%
0.00%
Q1 2019$448,000
-10.6%
174,456
-19.9%
0.00%
-100.0%
Q4 2018$501,000
-2.3%
217,809
+36.4%
0.00%
Q3 2018$513,000
-79.4%
159,645
-81.9%
0.00%
-100.0%
Q2 2018$2,495,000
+333.9%
881,685
+442.4%
0.00%
+100.0%
Q1 2018$575,000
-29.6%
162,550
-22.9%
0.00%0.0%
Q4 2017$817,000
+266.4%
210,751
+139.4%
0.00%
Q3 2017$223,000
-33.4%
88,030
-28.4%
0.00%
Q2 2017$335,000
-58.9%
122,980
-50.1%
0.00%
-100.0%
Q1 2017$816,000
-47.3%
246,476
-62.1%
0.00%
-50.0%
Q4 2016$1,547,000
+106.8%
649,790
+219.0%
0.00%
+100.0%
Q3 2016$748,000
+206.6%
203,702
+85.9%
0.00%
Q2 2016$244,000
+221.1%
109,602
+200.1%
0.00%
Q1 2016$76,000
-82.2%
36,523
-74.0%
0.00%
Q4 2015$426,000
+213.2%
140,517
+154.0%
0.00%
Q3 2015$136,000
-23.2%
55,321
+0.2%
0.00%
Q2 2015$177,000
+32.1%
55,211
+46.9%
0.00%
Q1 2015$134,000
+36.7%
37,596
-13.2%
0.00%
Q4 2014$98,000
-58.6%
43,297
-64.7%
0.00%
Q3 2014$237,000
+9.2%
122,485
+105.3%
0.00%
Q2 2014$217,000
-55.2%
59,669
-52.1%
0.00%
Q1 2014$484,000
-23.3%
124,631
-43.7%
0.00%
-100.0%
Q4 2013$631,000
+78.2%
221,223
+124.0%
0.00%
Q3 2013$354,000
-68.1%
98,747
-70.3%
0.00%
-100.0%
Q2 2013$1,109,000
+20.0%
332,186
+144.1%
0.00%0.0%
Q1 2013$924,000136,0970.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders